US5772629A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Localized intravascular delivery of TFPI for inhibition of restenosis in recanalized blood vessels
Assignee: LocalMed Inc
•
Filing: 1995-10-23
•
Granted: 1998-06-30
•
Expires: 2015-10-23
Abstract
Abstract Restenosis in recanalized blood vessels is inhibited by delivering tissue factor pathway inhibitor (TFPI) intramurally at a target site within the blood vessel. Usually, TFPI is delivered using a catheter having infusion ports at its distal end. Optionally at the distal end of the catheter is radially expanded to engage the infusion ports directly against the blood vessel wall.
Inventors
- 👤 Aaron V. Kaplan
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 23:04
CPC Classifications
A; A61; A61M; A61M25/00; A61M25/10; A61M25/104; A61K; A61K38/00; A61K38/16; A61K38/55; A61K38/57; A61M25/0021; A61M25/0023; A61P; A61P9/00; A61M25/1002; A61M2025/1004; A61M2025/1043; A61M2025/105; A61M2025/1072
Claims Analysis
Total Claims: 31
Claim 1
Independent Claim
37 words
A method for inhibiting abrupt closure and restenosis in a recanalized blood vessel, said method comprising intramurally delivering a TFPI polypeptide to a target site within the blood vessel in an amount sufficient to reduce platelet deposition.
Claim 2
Independent Claim
37 words
A method for inhibiting abrupt closure and restenosis in a recanalized blood vessel, said method comprising intramurally delivering a TFPI polypeptide to a target site within the blood vessel in an amount sufficient to reduce platelet deposition.
Claim 3
Dependent Claim
25 words
A method as in claim 1, wherein the amount of the TFPI polypeptide is from 0.1 μg to 10 mg per kg of body weight.
Claim 4
Dependent Claim
27 words
A method as in claim 2, wherein the total amount of TFPI polypeptide is delivered over a period in the range from 0.1 minute to 360 minutes.
Claim 5
Independent Claim
66 words
A method for inhibiting restenosis in a recanalized blood vessel, said method comprising: advancing a distal end of a catheter to a target site within the recanalized blood vessel; and delivering through the distal end of the catheter into the blood vessel wall an amount of a TFPI polypeptide sufficient to inhibit the accumulation of thrombus at said target site without substantially decreasing systemic clotting activity.
Claim 6
Independent Claim
66 words
A method for inhibiting restenosis in a recanalized blood vessel, said method comprising: advancing a distal end of a catheter to a target site within the recanalized blood vessel; and delivering through the distal end of the catheter into the blood vessel wall an amount of a TFPI polypeptide sufficient to inhibit the accumulation of thrombus at said target site without substantially decreasing systemic clotting activity.
Claim 7
Dependent Claim
27 words
A method as in claim 4, wherein the distal end of the catheter is introduced percutaneously to a patient's vasculature and advanced transluminally to the target site.
Claim 8
Dependent Claim
29 words
A method as in claim 4, wherein the TFPI polypeptide is delivered from a proximal end of the catheter, through a lumen in the catheter, to the distal end.
Claim 9
Dependent Claim
37 words
A method as in claim 4, further comprising expanding the distal end of the catheter to engage a plurality of infusion ports against the blood vessel wall, wherein the TFPI polypeptide is delivered through said infusion ports.
Claim 10
Dependent Claim
25 words
A method as in claim 4, wherein the amount of the TFPI polypeptide is from 0.1 μg to 10 mg per kg of body weight.
Claim 11
Dependent Claim
27 words
A method as in claim 8, wherein the total amount of TFPI polypeptide is delivered over a period in the range from 0.1 minute to 360 minutes.
Claim 12
Independent Claim
90 words
A method for inhibiting abrupt closure and restenosis in a recanalized blood vessel, said method comprising: advancing the distal end of an infusion catheter to a target site within the recanalized blood vessel; expanding the distal end of the infusion catheter to engage infusion ports on the catheter against the luminal wall of the blood vessel; and delivering through the infusion ports into the blood vessel wall an amount of a TFPI polypeptide sufficient to inhibit the accumulation of thrombus at said target site without substantially decreasing systemic clotting activity.
Claim 13
Independent Claim
90 words
A method for inhibiting abrupt closure and restenosis in a recanalized blood vessel, said method comprising: advancing the distal end of an infusion catheter to a target site within the recanalized blood vessel; expanding the distal end of the infusion catheter to engage infusion ports on the catheter against the luminal wall of the blood vessel; and delivering through the infusion ports into the blood vessel wall an amount of a TFPI polypeptide sufficient to inhibit the accumulation of thrombus at said target site without substantially decreasing systemic clotting activity.
Claim 14
Dependent Claim
27 words
A method as in claim 10, wherein the distal end of the catheter is introduced percutaneously to a patient's vasculature and advanced transluminally to the target site.
Claim 15
Dependent Claim
33 words
A method as in claim 10, wherein the TFPI polypeptide is delivered from a proximal end of the catheter, through a lumen in the catheter, to the infusion ports at the distal end.
Claim 16
Dependent Claim
43 words
A method as in claim 10, wherein the expanding step comprises inflating the distal end of the infusion catheter having the infusion ports with a fluid carrying the TFPI polypeptide with an inflation pressure to release the TFPI-containing fluid through the infusion ports.
Claim 17
Dependent Claim
31 words
A method as in claim 10, wherein the expanding step comprises: positioning a balloon within the distal end of the infusion catheter; and inflating the balloon to a predetermined inflation pressure.
Claim 18
Dependent Claim
32 words
A method as in claim 14, wherein the delivering step comprises supplying fluid to the infusion ports at a predetermined infusion pressure, wherein the infusion pressure is independent of the inflation pressure.
Claim 19
Dependent Claim
25 words
A method as in claim 10, wherein the amount of the TFPI polypeptide is from 0.1 μg to 10 mg per kg of body weight.
Claim 20
Dependent Claim
27 words
A method as in claim 16, wherein the total amount of TFPI polypeptide is delivered over a period in the range from 0.1 minute to 360 minutes.
Claim 21
Independent Claim
69 words
A method for recanalizing a blood vessel, said method comprising: enlarging the blood vessel lumen at a target site; advancing the distal end of an infusion catheter to the target site; and delivering through the distal end of the infusion catheter into the blood vessel wall an amount of a TFPI polypeptide sufficient to inhibit the accumulation of thrombus at said target site without substantially decreasing systemic clotting activity.
Claim 22
Independent Claim
69 words
A method for recanalizing a blood vessel, said method comprising: enlarging the blood vessel lumen at a target site; advancing the distal end of an infusion catheter to the target site; and delivering through the distal end of the infusion catheter into the blood vessel wall an amount of a TFPI polypeptide sufficient to inhibit the accumulation of thrombus at said target site without substantially decreasing systemic clotting activity.
Claim 23
Dependent Claim
27 words
A method as in claim 18, wherein the distal end of the catheter is introduced percutaneously to a patient's vasculature and advanced transluminally to the target site.
Claim 24
Dependent Claim
29 words
A method as in claim 18, wherein the TFPI polypeptide is delivered from a proximal end of the catheter, through a lumen in the catheter, to the distal end.
Claim 25
Dependent Claim
37 words
A method as in claim 18, further comprising expanding the distal end of the catheter to engage a plurality of infusion ports against the blood vessel wall, wherein the TFPI polypeptide is delivered through said infusion ports.
Claim 26
Dependent Claim
25 words
A method as in claim 18, wherein the amount of the TFPI polypeptide is from 0.1 μg to 10 mg per kg of body weight.
Claim 27
Dependent Claim
27 words
A method as in claim 22, wherein the total amount of TFPI polypeptide is delivered over a period in the range from 0.1 minute to 360 minutes.
Claim 28
Dependent Claim
19 words
A method as in claim 18, wherein the enlarging step comprises balloon angioplasty, atherectomy, laser recanalization, or stent placement.
Claim 29
Dependent Claim
43 words
A method as in claim 24, wherein the enlarging step comprises advancing an angioplasty balloon catheter to the treatment site, inflating a balloon at the distal end of the angioplasty balloon catheter to recanalize the blood vessel, and withdrawing the angioplasty balloon catheter.
Claim 30
Dependent Claim
27 words
A method as in claim 25, wherein the infusion catheter is advanced to the target site within one to ten minutes of withdrawing the angioplasty balloon catheter.
Claim 31
Dependent Claim
61 words
A method as in claim 25, further comprising placing the infusion catheter over the balloon angioplasty catheter after the withdrawal thereof, advancing the balloon angioplasty catheter together with the infusion catheter to the target site, and reinflating the balloon on the balloon angioplasty catheter to expand the distal end of the infusion catheter so that it contacts the blood vessel wall.
References Cited (Backward Citations)
US5106833A
Cited
US4966852A
Cited
US5021044A
Cited
US5049132A
Cited
EP0439442A2
Cited
EP0473564A1
Cited
US5278144A
Cited
US5180366A
Cited
WO1992011895A1
Cited
US5171217A
Cited
WO1993008866A1
Cited
US5212091A
Cited
US5276015A
Cited
WO1993024143A1
Cited
WO1993025230A1
Cited
WO1994002172A1
Cited
US5571086A
Cited
US5342348A
Cited
EP0604022A1
Cited
WO1994020537A1
Cited
WO1995002059A1
Cited
US5536250A
Cited
US5562620A
Cited
US5563123A
Cited
US5571784A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 2001-06-29 | 2001-12-29 | 2002-06-30 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2005-06-29 | 2005-12-29 | 2006-06-30 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2009-06-29 | 2009-12-29 | 2010-06-30 | $7700.00 | Window Closed / Lapsed |